Table 2 PHN pain severity/interference (ZBPI) and HRQOL impact (SF-36 & EQ-5D): ZQOL study subgroup analyses
Outcome variable | Age | Gender | Pain severity | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
Spearman’s rho | p | Male (n = 57) | Female (n = 95) | p | No pain (n = 15) | Mild (n = 42) | Moderate (n = 24) | Severe (n = 64) | p | |
Zoster Brief Pain Inventory (ZBPI) | ||||||||||
Pain severity | 0.2112 | ** | 4.1 | 4.0 | NS | N/A | N/A | N/A | N/A | N/A |
Pain interference | 0.1365 | NS | 2.6 | 3.1 | NS | 0.2 | 1.3 | 2.8 | 4.7 | ***† |
Short-Form Health Survey 36 (SF-36) | ||||||||||
SF-36 Physical Component Summary (PCS) | −0.2904 | *** | 39.2 | 37.9 | NS | 42.1 | 41.9 | 37.3 | 35.5 | * |
SF-36 Mental Component Summary (MCS) | −0.0527 | NS | 45.0 | 43.0 | NS | 47.8 | 49.5 | 46.6 | 37.7 | ***† |
EuroQoL 5-Dimensions (EQ-5D) | ||||||||||
EQ-5D Self-Rated Health (SRH) | −0.1506 | NS | 63.7 | 61.0 | NS | 65.5 | 69.7 | 62.0 | 56.6 | * |
EQ-5D Health State Index (HSI) | −0.1724 | NS | 0.54 | 0.56 | NS | 0.70 | 0.73 | 0.65 | 0.38 | ***† |